Clearmind Medicine Inc. Common Shares (CMND)

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$6.42

+0.13 (+2.08%)

Market Cap: $3.15M

Last updated: Oct 16, 2026 at 1:54 PM ET

Earnings

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jul 31, 2026Jul 26 Reported Sep 10, 2026Reported Sep 10	$-0.57	N/A	-	N/A	Beat	-	-	+94.2%
Apr 30, 2026Apr 26 Reported Jun 15, 2026Reported Jun 15	$-6.78	N/A	-	N/A	Beat	-	-	-4137.5%
Jan 31, 2026Jan 26 Reported Mar 12, 2026Reported Mar 12	$-33.17	N/A	-	N/A	Beat	-	-	-13720.5%
Oct 31, 2025Oct 25 Reported Jan 28, 2026Reported Jan 28	$-5.03	N/A	-	N/A	Beat	-	-	+93.9%
Jul 31, 2025Jul 25 Reported Sep 11, 2025Reported Sep 11	$-9.84	N/A	-	N/A	Beat	-	-	+95.8%
Apr 30, 2025Apr 25 Reported Jun 12, 2025Reported Jun 12	$-0.16	N/A	-	N/A	Beat	-	-	+99.9%
Jan 31, 2025Jan 25 Reported Mar 13, 2025Reported Mar 13	$-0.24	N/A	-	N/A	Beat	-	-	+99.9%
Oct 31, 2024Oct 24 Reported Jan 22, 2025Reported Jan 22	$-82.97	N/A	-	N/A	Beat	-	-	+98.2%
Jul 31, 2024Jul 24 Reported Sep 16, 2024Reported Sep 16	$-235.28	N/A	-	N/A	Beat	-	-	+75.8%
Apr 30, 2024Apr 24 Reported Jun 13, 2024Reported Jun 13	$-111.67	N/A	-	N/A	Beat	-	-	+98.3%
Jan 31, 2024Jan 24 Reported Mar 18, 2024Reported Mar 18	$-360.55	N/A	-	N/A	Beat	-	-	+96.2%
Oct 31, 2023Oct 23 Reported Jan 29, 2024Reported Jan 29	$-4575.59	N/A	-	N/A	Beat	-	-	+68.4%
Jul 31, 2023Jul 23 Reported Sep 13, 2023Reported Sep 13	$-973.68	N/A	-	N/A	Beat	-	-	+93.2%
Apr 30, 2023Apr 23 Reported Jun 14, 2023Reported Jun 14	$-6649.15	N/A	-	N/A	Beat	-	-	+71.1%
Jan 31, 2023Jan 23 Reported Feb 3, 2023Reported Feb 3	$-9524.72	N/A	-	N/A	Beat	-	-	+39.8%
Oct 31, 2022Oct 22 Reported Oct 31, 2022Reported Oct 31	$-14495.60	N/A	-	N/A	Beat	-	-	+24.9%
Jul 31, 2022Jul 22 Reported Jul 31, 2022Reported Jul 31	$-14305.95	N/A	-	N/A	Beat	-	-	-
Apr 30, 2022Apr 22 Reported Apr 30, 2022Reported Apr 30	$-22967.79	N/A	-	N/A	Beat	-	-	-
Jan 31, 2022Jan 22 Reported Apr 30, 2022Reported Apr 30	$-15824.06	N/A	-	N/A	Beat	-	-	-
Oct 31, 2021Oct 21 Reported Oct 31, 2021Reported Oct 31	$-19307.35	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-0.02	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-107.00%	ROIC	-56.82%
Financial Health
Debt/Equity	0.13x	Interest Coverage	-416.54x
Current Ratio	4.31x	Quick Ratio	4.31x
Trading Statistics
Beta	0.46	Avg Volume	161.79K
52-Week High	$3840.00	52-Week Low	$5.25

Technical Indicators Dashboard

Moving Averages

SMA 10$6.28

SMA 20$6.32

SMA 50$9.87

SMA 200$57.66

EMA 10$6.38

EMA 20$6.86

EMA 50$10.45

EMA 200$344.95

MACD

Line: -0.91Signal: -1.21Hist: 0.30

ADX

ADX: 51.8+DI: 6.9-DI: 0.9

Aroon & PSAR

Aroon Up80.0

Aroon Down64.0

PSAR$2.76

Bollinger Bands

Upper Band$6.91

Lower Band$5.73

%B Position1870%(Upper)

Band Width0.58

RSI (14-Day)

Neutral

37.7

Momentum Oscillators

Stoch %K86.9

Stoch %D87.8

Williams %R-11.5

ROC (10d)12.1%

Momentum0.69

CCI (20d)75.2

MFI (14d)50.7

Volatility Measures

ATR (14d)$4.20(65.4%)

StdDev (20d)0.30

Hist Vol82.5%(High)

Volume Flow

VWAP$6.38

OBV80.6M

AD Line26766.8B

CMF (20d)200.436

Volume Metrics

Avg Vol (20d)90.4K

Vol Ratio0.1x(Low)

VWMA (20d)$6.34

Pivot Points

R3$6.71

R2$6.59

R1$6.44

Pivot Point$6.32

S1$6.17

S2$6.05

S3$5.90

Advanced Oscillators

TSI-33.09

Ultimate Osc66.0

KST-303.41

Financial Data

Quarter	Jul 2026	Apr 2026	Jan 2026	Oct 2025	Jul 2025	Apr 2025	Jan 2025	Oct 2024	Jul 2024	Apr 2024	Jan 2024	Oct 2023
Total Revenue	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Cost of Revenue	$14,218	$13,901	$13,318	$12,836	$12,522	$11,978	$12,031	$11,511	$15,196	$15,730	$8,632	$4,011
Gross Profit	$-14,218	$-13,901	$-13,318	$-12,836	$-12,522	$-11,978	$-12,031	$-11,511	$-15,196	$-15,730	$-8,632	$-4,011

Operating Expenses	$2.17M	$1.56M	$3.64M	$1.44M	$1.40M	$1.30M	$1.48M	$1.57M	$1.46M	$1.29M	$1.38M	$1.71M
R&D	$586,197	$644,036	$637,344	$417,382	$720,288	$449,521	$458,428	$483,729	$343,251	$320,114	$224,753	$374,561
SG&A	$1.59M	$924,502	$3.02M	$997,661	$948,742	$855,124	$1.03M	$1.06M	$1.13M	$980,549	$1.16M	$943,656
Operating Income	$-2,179,875	$-1,571,209	$-3,657,688	$-1,456,123	$-1,407,765	$-1,307,958	$-1,495,362	$-1,586,178	$-1,471,805	$-1,302,933	$-1,384,214	N/A

Interest Income	$106,961	$42,025	$64,649	$24,659	$32,593	$41,648	$34,008	$91,669	$85,024	$33,955	$60,576	$60,576
Interest Expense	$5,306	$4,233	$4,103	$6,238	$9,192	$7,873	$8,710	$36,160	$61,408	$0	$2,926	$5,999
Income Before Tax	$-904,061	$-2,044,341	$-3,848,280	$-685,584	$-1,305,335	$-763,840	$-1,031,725	$-787,622	$-2,052,104	$-871,079	$-1,166,488	$-4,052,911
Income Tax Expense	$3,230	$3,311	$3,957	$0	$8,257	$20,673	$39,313	$97,119	$42,605	$36,739	$201,531	$11,337

Net Income	$-907,291	$-2,047,653	$-3,852,238	$-687,777	$-1,313,593	$-784,513	$-1,071,039	$-884,742	$-2,094,710	$-907,818	$-1,368,021	N/A

EBITDA	$-2,165,657	$-1,557,308	$-3,830,859	$-672,748	$-1,283,618	$-743,992	$-1,010,977	$-1,179,886	$-2,036,914	$-855,338	$-1,157,853	$-4,048,899
EBIT	$-2,179,875	$-1,571,209	$-3,844,177	$-685,586	$-1,296,141	$-755,962	$-1,023,015	$-1,191,398	$-2,052,105	$-871,076	$-1,166,484	$-4,052,916

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about CMND

News

Robotaxis could recharge without plugs. Clearmind's subsidiary launched the system.

Clearmind Medicine announced that its 51%-owned subsidiary, Charging Robotics, has launched a next-generation autonomous EV charging platform. This system is designed for robotaxis, autonomous fleets...

Stock Titan•Oct 12, 2026 7:41 AM ET10/12/26•Somewhat-Bullish

EBITDA per share of Clearmind Medicine Inc. – MUN:CWY1

This article provides financial data for Clearmind Medicine Inc. (MUN:CWY1), specifically focusing on its EBITDA per share. It is presented as part of a larger financial overview on TradingView...

TradingView•Oct 9, 2026 10:11 AM ET10/9/26•Neutral

Total revenue of Clearmind Medicine Inc. – FWB:CWY1

This article provides financial information for Clearmind Medicine Inc. (FWB:CWY1) listed on the Frankfurt Stock Exchange. It specifically highlights the total revenue data for the company...

TradingView•Oct 8, 2026 8:40 PM ET10/8/26•Neutral

Basic earnings per share (basic EPS) of Clearmind Medicine Inc. – MUN:CWY1

This article displays the basic earnings per share (basic EPS) for Clearmind Medicine Inc. (MUN:CWY1) on the Munich Stock Exchange. The market is currently closed with no trades. The content primarily focuses...

TradingView•Oct 8, 2026 6:02 PM ET10/8/26•Neutral

Clearmind Medicine says Japan published patent filing

Clearmind Medicine Inc. announced that Japan has published a patent application for its proposed dyskinesia treatment...

Mugglehead Investment Magazine•Oct 8, 2026 1:02 PM ET10/8/26•Neutral

CMND Valuation and Fair Value

P/E: -0.0x
P/B: 0.1x

See GNG's fair value

CMND Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROIC: -56.8%
ROE: -107.0%

CMND Competitors

Company	Ticker
Calidi Biotherapeutics Inc.	CLDI
60 Degrees Pharmaceuticals, Inc. Common Stock	SXTP
IO Biotech Inc	IOBT
Cadrenal Therapeutics, Inc. Common Stock	CVKD
Mainz Biomed BV	MYNZ
Mustang Bio Inc	MBIO
Sunshine Biopharma Inc	SBFM
GRI Bio Inc.	GRI

Sector: Healthcare

Frequently Asked Questions About CMND

Does CMND pay dividends?

Clearmind Medicine Inc. Common Shares (CMND) does not currently pay a regular dividend.

What is CMND's market cap?

Clearmind Medicine Inc. Common Shares (CMND) has a market capitalization of $3.15M with a current stock price of $6.42.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In